Resources

A review of two intensive therapies to lower blood glucose levels in newly diagnosed Type 2 patients…

Certain urine proteomic profiles may be useful biomarkers in the differential diagnosis of diabetic glomerulosclerosis, researchers report in Diabetes Care… 

Intensive dietary advice has the potential to appreciably improve glycemic control and anthropometric measures in patients with Type 2 diabetes who are hyperglycemic despite optimized drug treatment… 

Given the prevalence of lipid abnormalities in patients with diabetes, dual PPAR-α/γ agonists (glitazars) could potentially benefit patients with diabetes. A phase II trial examining a novel dual PPAR agonist, aleglitazar, showed that therapy with this agent reduced hyperglycemia and favorably modified levels of HDL-C and triglycerides with an acceptable …

A third of patients on lipid-lowering therapy received inadequate doses of generic simvastatin after being switched from atorvastatin (Lipitor), an analysis of a large pharmacy database showed…  

A daily coffee habit may counteract aortic stiffness in older adults with hypertension, researchers reported…

Diabetes patients who take insulin have a higher risk of developing cancer, according to Danish researchers who say they can’t explain the link…  

Common office-based measures in childhood appear to predict the chances of having Type 2 diabetes later in life, researchers found…  

Elevated A1c (≥5.5–6.0%) was associated with incident heart failure in a middle-aged population without diabetes, suggesting that chronic hyperglycemia prior to the development of diabetes contributes to development of heart failure…

Mothers who breastfeed their children have a considerably lower risk of developing Type 2 diabetes when they are older compared to women who have never breastfed, according to researchers….